These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 20818426)

  • 21. Down-regulation of myopodin expression reduces invasion and motility of PC-3 prostate cancer cells.
    De Ganck A; De Corte V; Bruyneel E; Bracke M; Vandekerckhove J; Gettemans J
    Int J Oncol; 2009 May; 34(5):1403-9. PubMed ID: 19360353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples.
    Xiong J; Yu D; Wei N; Fu H; Cai T; Huang Y; Wu C; Zheng X; Du Q; Lin D; Liang Z
    FEBS J; 2010 Apr; 277(7):1684-94. PubMed ID: 20180843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer.
    Uhlmann S; Zhang JD; Schwäger A; Mannsperger H; Riazalhosseini Y; Burmester S; Ward A; Korf U; Wiemann S; Sahin O
    Oncogene; 2010 Jul; 29(30):4297-306. PubMed ID: 20514023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
    Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
    Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
    Darnel AD; Behmoaram E; Vollmer RT; Corcos J; Bijian K; Sircar K; Su J; Jiao J; Alaoui-Jamali MA; Bismar TA
    Clin Cancer Res; 2009 Feb; 15(4):1376-83. PubMed ID: 19228738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
    Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
    Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.
    Grothey A; Hashizume R; Ji H; Tubb BE; Patrick CW; Yu D; Mooney EE; McCrea PD
    Oncogene; 2000 Oct; 19(42):4864-75. PubMed ID: 11039904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of microRNA-145 for therapeutic application in breast cancer.
    Kim SJ; Oh JS; Shin JY; Lee KD; Sung KW; Nam SJ; Chun KH
    J Control Release; 2011 Nov; 155(3):427-34. PubMed ID: 21723890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
    Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
    Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton.
    Li X; Law JW; Lee AY
    Oncogene; 2012 Feb; 31(5):595-610. PubMed ID: 21706053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
    Davies S; Jiang WG
    Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.
    Gong B; Hu H; Chen J; Cao S; Yu J; Xue J; Chen F; Cai Y; He H; Zhang L
    Biomed Pharmacother; 2013 Sep; 67(7):629-36. PubMed ID: 23953883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro.
    Jawhari AU; Buda A; Jenkins M; Shehzad K; Sarraf C; Noda M; Farthing MJ; Pignatelli M; Adams JC
    Am J Pathol; 2003 Jan; 162(1):69-80. PubMed ID: 12507891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma.
    Nohata N; Hanazawa T; Kikkawa N; Sakurai D; Sasaki K; Chiyomaru T; Kawakami K; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Oncol; 2011 Nov; 39(5):1099-107. PubMed ID: 21701775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement.
    Dinicola S; Fabrizi G; Masiello MG; Proietti S; Palombo A; Minini M; Harrath AH; Alwasel SH; Ricci G; Catizone A; Cucina A; Bizzarri M
    Exp Cell Res; 2016 Jul; 345(1):37-50. PubMed ID: 27237097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator-stimulated phosphoprotein.
    Wang J; Zhang J; Wu J; Luo D; Su K; Shi W; Liu J; Tian Y; Wei L
    Eur J Cancer; 2012 Aug; 48(12):1904-13. PubMed ID: 22189055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from flax lignan, and down-regulation of matrix metalloproteinases in MCF-7 and MDA MB 231 cell lines.
    Mali AV; Wagh UV; Hegde MV; Chandorkar SS; Surve SV; Patole MV
    Indian J Cancer; 2012; 49(1):181-7. PubMed ID: 22842186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.